Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 105 entries
Sorted by: Best Match Show Resources per page
Germline whole exome sequencing and large-scale replication identifies .

Oncotarget

Dicks E, Song H, Ramus SJ, Oudenhove EV, Tyrer JP, Intermaggio MP, Kar S, Harrington P, Bowtell DD, Group AS, Cicek MS, Cunningham JM, Fridley BL, Alsop J, Jimenez-Linan M, Piskorz A, Goranova T, Kent E, Siddiqui N, Paul J, Crawford R, Poblete S, Lele S, Sucheston-Campbell L, Moysich KB, Sieh W, McGuire V, Lester J, Odunsi K, Whittemore AS, Bogdanova N, Dürst M, Hillemanns P, Karlan BY, Gentry-Maharaj A, Menon U, Tischkowitz M, Levine D, Brenton JD, Dörk T, Goode EL, Gayther SA, Pharoah DPP.
PMID: 28881617
Oncotarget. 2017 Mar 03;8(31):50930-50940. doi: 10.18632/oncotarget.15871. eCollection 2017 Aug 01.

We analyzed whole exome sequencing data in germline DNA from 412 high grade serous ovarian cancer (HGSOC) cases from The Cancer Genome Atlas Project and identified 5,517 genes harboring a predicted deleterious germline coding mutation in at least one...

Cite
Dicks E, Song H, Ramus SJ, et al. Germline whole exome sequencing and large-scale replication identifies . Oncotarget. 2017;8(31):50930-50940doi: 10.18632/oncotarget.15871.
Dicks, E., Song, H., Ramus, S. J., Oudenhove, E. V., Tyrer, J. P., Intermaggio, M. P., Kar, S., Harrington, P., Bowtell, D. D., Group, A. S., Cicek, M. S., Cunningham, J. M., Fridley, B. L., Alsop, J., Jimenez-Linan, M., Piskorz, A., Goranova, T., Kent, E., Siddiqui, N., Paul, J., Crawford, R., Poblete, S., Lele, S., Sucheston-Campbell, L., Moysich, K. B., Sieh, W., McGuire, V., Lester, J., Odunsi, K., Whittemore, A. S., Bogdanova, N., Dürst, M., Hillemanns, P., Karlan, B. Y., Gentry-Maharaj, A., Menon, U., Tischkowitz, M., Levine, D., Brenton, J. D., Dörk, T., Goode, E. L., Gayther, S. A., & Pharoah, D. P. P. (2017). Germline whole exome sequencing and large-scale replication identifies . Oncotarget, 8(31), 50930-50940. https://doi.org/10.18632/oncotarget.15871
Dicks, Ed, et al. "Germline whole exome sequencing and large-scale replication identifies ." Oncotarget vol. 8,31 (2017): 50930-50940. doi: https://doi.org/10.18632/oncotarget.15871
Dicks E, Song H, Ramus SJ, Oudenhove EV, Tyrer JP, Intermaggio MP, Kar S, Harrington P, Bowtell DD, Group AS, Cicek MS, Cunningham JM, Fridley BL, Alsop J, Jimenez-Linan M, Piskorz A, Goranova T, Kent E, Siddiqui N, Paul J, Crawford R, Poblete S, Lele S, Sucheston-Campbell L, Moysich KB, Sieh W, McGuire V, Lester J, Odunsi K, Whittemore AS, Bogdanova N, Dürst M, Hillemanns P, Karlan BY, Gentry-Maharaj A, Menon U, Tischkowitz M, Levine D, Brenton JD, Dörk T, Goode EL, Gayther SA, Pharoah DPP. Germline whole exome sequencing and large-scale replication identifies . Oncotarget. 2017 Mar 03;8(31):50930-50940. doi: 10.18632/oncotarget.15871. eCollection 2017 Aug 01. PMID: 28881617; PMCID: PMC5584218.
Copy Download .nbib Format: NLM
Secondary Data Analytics of Aquaporin Expression Levels in Glioblastoma Stem-Like Cells.

Cancer informatics

Isokpehi RD, Wollenberg Valero KC, Graham BE, Pacurari M, Sims JN, Udensi UK, Ndebele K.
PMID: 26279619
Cancer Inform. 2015 Jul 30;14:95-103. doi: 10.4137/CIN.S22058. eCollection 2015.

Glioblastoma is the most common brain tumor in adults in which recurrence has been attributed to the presence of cancer stem cells in a hypoxic microenvironment. On the basis of tumor formation in vivo and growth type in vitro,...

Cite
Isokpehi RD, Wollenberg Valero KC, Graham BE, et al. Secondary Data Analytics of Aquaporin Expression Levels in Glioblastoma Stem-Like Cells. Cancer Inform. 2015;14:95-103doi: 10.4137/CIN.S22058.
Isokpehi, R. D., Wollenberg Valero, K. C., Graham, B. E., Pacurari, M., Sims, J. N., Udensi, U. K., & Ndebele, K. (2015). Secondary Data Analytics of Aquaporin Expression Levels in Glioblastoma Stem-Like Cells. Cancer informatics, 1495-103. https://doi.org/10.4137/CIN.S22058
Isokpehi, Raphael D, et al. "Secondary Data Analytics of Aquaporin Expression Levels in Glioblastoma Stem-Like Cells." Cancer informatics vol. 14 (2015): 95-103. doi: https://doi.org/10.4137/CIN.S22058
Isokpehi RD, Wollenberg Valero KC, Graham BE, Pacurari M, Sims JN, Udensi UK, Ndebele K. Secondary Data Analytics of Aquaporin Expression Levels in Glioblastoma Stem-Like Cells. Cancer Inform. 2015 Jul 30;14:95-103. doi: 10.4137/CIN.S22058. eCollection 2015. PMID: 26279619; PMCID: PMC4524166.
Copy Download .nbib Format: NLM
Evaluative profiling of arsenic sensing and regulatory systems in the human microbiome project genomes.

Microbiology insights

Isokpehi RD, Udensi UK, Simmons SS, Hollman AL, Cain AE, Olofinsae SA, Hassan OA, Kashim ZA, Enejoh OA, Fasesan DE, Nashiru O.
PMID: 25452698
Microbiol Insights. 2014 Nov 11;7:25-34. doi: 10.4137/MBI.S18076. eCollection 2014.

The influence of environmental chemicals including arsenic, a type 1 carcinogen, on the composition and function of the human-associated microbiota is of significance in human health and disease. We have developed a suite of bioinformatics and visual analytics methods...

Cite
Isokpehi RD, Udensi UK, Simmons SS, et al. Evaluative profiling of arsenic sensing and regulatory systems in the human microbiome project genomes. Microbiol Insights. 2014;7:25-34doi: 10.4137/MBI.S18076.
Isokpehi, R. D., Udensi, U. K., Simmons, S. S., Hollman, A. L., Cain, A. E., Olofinsae, S. A., Hassan, O. A., Kashim, Z. A., Enejoh, O. A., Fasesan, D. E., & Nashiru, O. (2014). Evaluative profiling of arsenic sensing and regulatory systems in the human microbiome project genomes. Microbiology insights, 725-34. https://doi.org/10.4137/MBI.S18076
Isokpehi, Raphael D, et al. "Evaluative profiling of arsenic sensing and regulatory systems in the human microbiome project genomes." Microbiology insights vol. 7 (2014): 25-34. doi: https://doi.org/10.4137/MBI.S18076
Isokpehi RD, Udensi UK, Simmons SS, Hollman AL, Cain AE, Olofinsae SA, Hassan OA, Kashim ZA, Enejoh OA, Fasesan DE, Nashiru O. Evaluative profiling of arsenic sensing and regulatory systems in the human microbiome project genomes. Microbiol Insights. 2014 Nov 11;7:25-34. doi: 10.4137/MBI.S18076. eCollection 2014. PMID: 25452698; PMCID: PMC4230230.
Copy Download .nbib Format: NLM
Cryomyolysis in the management of uterine fibroids: technique and complications.

Surgical technology international

Odnusi KO, Rutherford TJ, Olive DL, Bia F, Parkash V, Brown J, Zreik TG.
PMID: 12451527
Surg Technol Int. 1999;8:173-8.

Uterine fibroids are common benign tumors of the uterus and a major public health problem. Between 20 and 25% of women over 35 years of age are estimated to have fibroids. Three subtypes of fibroids are recognized depending on...

Cite
Odnusi KO, Rutherford TJ, Olive DL, et al. Cryomyolysis in the management of uterine fibroids: technique and complications. Surg Technol Int. 1999;8:173-8
Odnusi, K. O., Rutherford, T. J., Olive, D. L., Bia, F., Parkash, V., Brown, J., & Zreik, T. G. (1999). Cryomyolysis in the management of uterine fibroids: technique and complications. Surgical technology international, 8173-8.
Odnusi, K O, et al. "Cryomyolysis in the management of uterine fibroids: technique and complications." Surgical technology international vol. 8 (1999): 173-8.
Odnusi KO, Rutherford TJ, Olive DL, Bia F, Parkash V, Brown J, Zreik TG. Cryomyolysis in the management of uterine fibroids: technique and complications. Surg Technol Int. 1999;8:173-8. PMID: 12451527.
Copy Download .nbib Format: NLM
Principles of Evidence Based Screening for Cancers.

Surgical technology international

Odunsi K, Pejovic T, Savalgi R.
PMID: 12219314
Surg Technol Int. 2000 Oct;318-332.

Cancer is a major public health concern. Current estimates suggest that approximately 3 out of every 10 people will be diagnosed with cancer at some point during their lifetime. The American Cancer Society (ACS) estimates that about 1.25 million...

Cite
Odunsi K, Pejovic T, Savalgi R. Principles of Evidence Based Screening for Cancers. Surg Technol Int. 2000;318-332
Odunsi, K., Pejovic, T., & Savalgi, R. (2000). Principles of Evidence Based Screening for Cancers. Surgical technology international, 318-332.
Odunsi, Kunle, et al. "Principles of Evidence Based Screening for Cancers." Surgical technology international vol. (2000): 318-332.
Odunsi K, Pejovic T, Savalgi R. Principles of Evidence Based Screening for Cancers. Surg Technol Int. 2000 Oct;318-332. PMID: 12219314.
Copy Download .nbib Format: NLM
Deep depletion of abundant serum proteins reveals low-abundant proteins as potential biomarkers for human ovarian cancer.

Proteomics. Clinical applications

Lin B, White JT, Wu J, Lele S, Old LJ, Hood L, Odunsi K.
PMID: 20559449
Proteomics Clin Appl. 2009 Jul 01;3(7):853-861. doi: 10.1002/prca.200800141.

Epithelial ovarian cancer (EOC) ranks fifth as a cause of cancer deaths in women. Current diagnostic and monitoring markers have limited reliability for the detection of disease. We have tested the possibility of identifying candidate biomarkers present at low...

Cite
Lin B, White JT, Wu J, et al. Deep depletion of abundant serum proteins reveals low-abundant proteins as potential biomarkers for human ovarian cancer. Proteomics Clin Appl. 2009;3(7):853-861doi: 10.1002/prca.200800141.
Lin, B., White, J. T., Wu, J., Lele, S., Old, L. J., Hood, L., & Odunsi, K. (2009). Deep depletion of abundant serum proteins reveals low-abundant proteins as potential biomarkers for human ovarian cancer. Proteomics. Clinical applications, 3(7), 853-861. https://doi.org/10.1002/prca.200800141
Lin, Biaoyang, et al. "Deep depletion of abundant serum proteins reveals low-abundant proteins as potential biomarkers for human ovarian cancer." Proteomics. Clinical applications vol. 3,7 (2009): 853-861. doi: https://doi.org/10.1002/prca.200800141
Lin B, White JT, Wu J, Lele S, Old LJ, Hood L, Odunsi K. Deep depletion of abundant serum proteins reveals low-abundant proteins as potential biomarkers for human ovarian cancer. Proteomics Clin Appl. 2009 Jul 01;3(7):853-861. doi: 10.1002/prca.200800141. PMID: 20559449; PMCID: PMC2886282.
Copy Download .nbib Format: NLM
Interprofessional faculty development: integration of oral health into the geriatric diabetes curriculum, from theory to practice.

Journal of multidisciplinary healthcare

Dounis G, Ditmyer M, Vanbeuge S, Schuerman S, McClain M, Dounis K, Mobley C.
PMID: 24363558
J Multidiscip Healthc. 2013 Dec 09;7:1-9. doi: 10.2147/JMDH.S54851. eCollection 2013.

BACKGROUND: Health care workforce shortages and an increase demand for health care services by an older demographic challenged by oral-systemic conditions are being recognized across health care systems. Demands are placed on health care professionals to render coordinated delivery...

Cite
Dounis G, Ditmyer M, Vanbeuge S, et al. Interprofessional faculty development: integration of oral health into the geriatric diabetes curriculum, from theory to practice. J Multidiscip Healthc. 2013;7:1-9doi: 10.2147/JMDH.S54851.
Dounis, G., Ditmyer, M., Vanbeuge, S., Schuerman, S., McClain, M., Dounis, K., & Mobley, C. (2013). Interprofessional faculty development: integration of oral health into the geriatric diabetes curriculum, from theory to practice. Journal of multidisciplinary healthcare, 71-9. https://doi.org/10.2147/JMDH.S54851
Dounis, Georgia, et al. "Interprofessional faculty development: integration of oral health into the geriatric diabetes curriculum, from theory to practice." Journal of multidisciplinary healthcare vol. 7 (2013): 1-9. doi: https://doi.org/10.2147/JMDH.S54851
Dounis G, Ditmyer M, Vanbeuge S, Schuerman S, McClain M, Dounis K, Mobley C. Interprofessional faculty development: integration of oral health into the geriatric diabetes curriculum, from theory to practice. J Multidiscip Healthc. 2013 Dec 09;7:1-9. doi: 10.2147/JMDH.S54851. eCollection 2013. PMID: 24363558; PMCID: PMC3862736.
Copy Download .nbib Format: NLM
Decreased levels of serum glutathione peroxidase 3 are associated with papillary serous ovarian cancer and disease progression.

Journal of ovarian research

Agnani D, Camacho-Vanegas O, Camacho C, Lele S, Odunsi K, Cohen S, Dottino P, Martignetti JA.
PMID: 22017790
J Ovarian Res. 2011 Oct 22;4:18. doi: 10.1186/1757-2215-4-18.

BACKGROUND: Glutathione peroxidase 3 (GPX3) is a selenocysteine-containing antioxidant enzyme that reacts with hydrogen peroxide and soluble fatty acid hydroperoxides, thereby helping to maintain redox balance within cells. Serum levels of GPX3 have been found to be reduced in...

Cite
Agnani D, Camacho-Vanegas O, Camacho C, et al. Decreased levels of serum glutathione peroxidase 3 are associated with papillary serous ovarian cancer and disease progression. J Ovarian Res. 2011;4:18doi: 10.1186/1757-2215-4-18.
Agnani, D., Camacho-Vanegas, O., Camacho, C., Lele, S., Odunsi, K., Cohen, S., Dottino, P., & Martignetti, J. A. (2011). Decreased levels of serum glutathione peroxidase 3 are associated with papillary serous ovarian cancer and disease progression. Journal of ovarian research, 418. https://doi.org/10.1186/1757-2215-4-18
Agnani, Deep, et al. "Decreased levels of serum glutathione peroxidase 3 are associated with papillary serous ovarian cancer and disease progression." Journal of ovarian research vol. 4 (2011): 18. doi: https://doi.org/10.1186/1757-2215-4-18
Agnani D, Camacho-Vanegas O, Camacho C, Lele S, Odunsi K, Cohen S, Dottino P, Martignetti JA. Decreased levels of serum glutathione peroxidase 3 are associated with papillary serous ovarian cancer and disease progression. J Ovarian Res. 2011 Oct 22;4:18. doi: 10.1186/1757-2215-4-18. PMID: 22017790; PMCID: PMC3213073.
Copy Download .nbib Format: NLM
Candidate single nucleotide polymorphism markers for arsenic responsiveness of protein targets.

Bioinformatics and biology insights

Isokpehi RD, Cohly HH, Anyanwu MN, Rajnarayanan RV, Tchounwou PB, Udensi UK, Graham-Evans BE.
PMID: 20981267
Bioinform Biol Insights. 2010 Oct 11;4:99-111. doi: 10.4137/BBI.S5498.

Arsenic is a toxic metalloid that causes skin cancer and binds to cysteine residues-a property that could be used to infer arsenic responsiveness of a target protein. Non-synonymous Single Nucleotide Polymorphisms (nsSNPs) result in amino acid substitutions and may...

Cite
Isokpehi RD, Cohly HH, Anyanwu MN, et al. Candidate single nucleotide polymorphism markers for arsenic responsiveness of protein targets. Bioinform Biol Insights. 2010;4:99-111doi: 10.4137/BBI.S5498.
Isokpehi, R. D., Cohly, H. H., Anyanwu, M. N., Rajnarayanan, R. V., Tchounwou, P. B., Udensi, U. K., & Graham-Evans, B. E. (2010). Candidate single nucleotide polymorphism markers for arsenic responsiveness of protein targets. Bioinformatics and biology insights, 499-111. https://doi.org/10.4137/BBI.S5498
Isokpehi, Raphael D, et al. "Candidate single nucleotide polymorphism markers for arsenic responsiveness of protein targets." Bioinformatics and biology insights vol. 4 (2010): 99-111. doi: https://doi.org/10.4137/BBI.S5498
Isokpehi RD, Cohly HH, Anyanwu MN, Rajnarayanan RV, Tchounwou PB, Udensi UK, Graham-Evans BE. Candidate single nucleotide polymorphism markers for arsenic responsiveness of protein targets. Bioinform Biol Insights. 2010 Oct 11;4:99-111. doi: 10.4137/BBI.S5498. PMID: 20981267; PMCID: PMC2964045.
Copy Download .nbib Format: NLM
Inactivating Mutations in GT198 in Familial and Early-Onset Breast and Ovarian Cancers.

Genes & cancer

Peng M, Bakker JL, Dicioccio RA, Gille JJ, Zhao H, Odunsi K, Sucheston L, Jaafar L, Mivechi NF, Waisfisz Q, Ko L.
PMID: 23946868
Genes Cancer. 2013 Jan;4(1):15-25. doi: 10.1177/1947601913486344.

The human GT198 gene (gene symbol PSMC3IP) is located at chromosome 17q21, 470 kb proximal to BRCA1, a locus previously linked to breast and ovarian cancer predisposition. Its protein product (also known as TBPIP and Hop2) has been shown...

Cite
Peng M, Bakker JL, Dicioccio RA, et al. Inactivating Mutations in GT198 in Familial and Early-Onset Breast and Ovarian Cancers. Genes Cancer. 2013;4(1):15-25doi: 10.1177/1947601913486344.
Peng, M., Bakker, J. L., Dicioccio, R. A., Gille, J. J., Zhao, H., Odunsi, K., Sucheston, L., Jaafar, L., Mivechi, N. F., Waisfisz, Q., & Ko, L. (2013). Inactivating Mutations in GT198 in Familial and Early-Onset Breast and Ovarian Cancers. Genes & cancer, 4(1), 15-25. https://doi.org/10.1177/1947601913486344
Peng, Min, et al. "Inactivating Mutations in GT198 in Familial and Early-Onset Breast and Ovarian Cancers." Genes & cancer vol. 4,1 (2013): 15-25. doi: https://doi.org/10.1177/1947601913486344
Peng M, Bakker JL, Dicioccio RA, Gille JJ, Zhao H, Odunsi K, Sucheston L, Jaafar L, Mivechi NF, Waisfisz Q, Ko L. Inactivating Mutations in GT198 in Familial and Early-Onset Breast and Ovarian Cancers. Genes Cancer. 2013 Jan;4(1):15-25. doi: 10.1177/1947601913486344. PMID: 23946868; PMCID: PMC3743154.
Copy Download .nbib Format: NLM
Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer.

Oncoimmunology

Huang RY, Francois A, McGray AR, Miliotto A, Odunsi K.
PMID: 28197366
Oncoimmunology. 2016 Oct 28;6(1):e1249561. doi: 10.1080/2162402X.2016.1249561. eCollection 2017.

Tumor-associated or -infiltrating lymphocytes (TALs or TILs) co-express multiple immune inhibitory receptors that contribute to immune suppression in the ovarian tumor microenvironment (TME). Dual blockade of PD-1 along with LAG-3 or CTLA-4 has been shown to synergistically enhance T-cell...

Cite
Huang RY, Francois A, McGray AR, et al. Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer. Oncoimmunology. 2016;6(1):e1249561doi: 10.1080/2162402X.2016.1249561.
Huang, R. Y., Francois, A., McGray, A. R., Miliotto, A., & Odunsi, K. (2017). Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer. Oncoimmunology, 6(1), e1249561. https://doi.org/10.1080/2162402X.2016.1249561
Huang, Ruea-Yea, et al. "Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer." Oncoimmunology vol. 6,1 (2017): e1249561. doi: https://doi.org/10.1080/2162402X.2016.1249561
Huang RY, Francois A, McGray AR, Miliotto A, Odunsi K. Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer. Oncoimmunology. 2016 Oct 28;6(1):e1249561. doi: 10.1080/2162402X.2016.1249561. eCollection 2017. PMID: 28197366; PMCID: PMC5283642.
Copy Download .nbib Format: NLM
Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients.

Oncoimmunology

Berinstein NL, Karkada M, Oza AM, Odunsi K, Villella JA, Nemunaitis JJ, Morse MA, Pejovic T, Bentley J, Buyse M, Nigam R, Weir GM, MacDonald LD, Quinton T, Rajagopalan R, Sharp K, Penwell A, Sammatur L, Burzykowski T, Stanford MM, Mansour M.
PMID: 26405584
Oncoimmunology. 2015 May 07;4(8):e1026529. doi: 10.1080/2162402X.2015.1026529. eCollection 2015 Aug.

DepoVax™ is an innovative and strongly immunogenic vaccine platform. Survivin is highly expressed in many tumor types and has reported prognostic value. To generate tumor-specific immune response, a novel cancer vaccine was formulated in DepoVax platform (DPX-Survivac) using survivin...

Cite
Berinstein NL, Karkada M, Oza AM, et al. Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients. Oncoimmunology. 2015;4(8):e1026529doi: 10.1080/2162402X.2015.1026529.
Berinstein, N. L., Karkada, M., Oza, A. M., Odunsi, K., Villella, J. A., Nemunaitis, J. J., Morse, M. A., Pejovic, T., Bentley, J., Buyse, M., Nigam, R., Weir, G. M., MacDonald, L. D., Quinton, T., Rajagopalan, R., Sharp, K., Penwell, A., Sammatur, L., Burzykowski, T., Stanford, M. M., & Mansour, M. (2015). Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients. Oncoimmunology, 4(8), e1026529. https://doi.org/10.1080/2162402X.2015.1026529
Berinstein, Neil L, et al. "Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients." Oncoimmunology vol. 4,8 (2015): e1026529. doi: https://doi.org/10.1080/2162402X.2015.1026529
Berinstein NL, Karkada M, Oza AM, Odunsi K, Villella JA, Nemunaitis JJ, Morse MA, Pejovic T, Bentley J, Buyse M, Nigam R, Weir GM, MacDonald LD, Quinton T, Rajagopalan R, Sharp K, Penwell A, Sammatur L, Burzykowski T, Stanford MM, Mansour M. Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients. Oncoimmunology. 2015 May 07;4(8):e1026529. doi: 10.1080/2162402X.2015.1026529. eCollection 2015 Aug. PMID: 26405584; PMCID: PMC4570133.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 105 entries